Diseases, Conditions, Syndromes

Fecal microbiota transplant cost-effective for preventing CDI

(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...

Medications

Vibativ approved for certain bacterial pneumonia

(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Diseases, Conditions, Syndromes

Vancomycin powder doesn't cut infection post-spine surgery

(HealthDay)—For patients undergoing spinal procedures, the local application of vancomycin powder in surgical wounds does not significantly reduce the incidence of infection, according to a study published in the Dec. 1 ...

Oncology & Cancer

Fidaxomicin ups outcome of C. difficile-tied diarrhea in cancer

(HealthDay)—For patients with cancer with Clostridium difficile-associated diarrhea (CDAD), fidaxomicin treatment is associated with improved outcomes compared with vancomycin treatment, according to research published ...

Diseases, Conditions, Syndromes

How superbug spreads among regional hospitals: A domino effect

A moderate increase in vancomycin-resistant enterococci (VRE) at one hospital can lead to a nearly 3 percent increase in VRE in every other hospital in that county, according to a study in the August issue of the American ...

Diseases, Conditions, Syndromes

Wide discrepancy in surveillance and control of infections in ICUs

Screening practices for multidrug-resistant organisms (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study by researchers at Columbia University School of Nursing and published ...

page 5 from 7